Tags

Type your tag names separated by a space and hit enter

[Usefulness of transdermal hormone substitution in high risk postmenopausal patients].
Orv Hetil 1996; 137(37):2025-8OH

Abstract

The authors studied whether hormone replacement therapy can be performed in postmenopausal patients with high risk factors among anamnestic data such as thromboembolia, diabetes mellitus, hypertension, epilepsy. 50 mg 17 beta estradiol patch (twice weekly) and 10 mg medroxyprogesteron (in the last 12 days of the cycle) were prescribed. Data of 102 patients with the above conditions were analyzed at the beginning and at the 3,6, and 12 month follow-up visits. The frequency of exacerbation of anamnestic disease, biased and unbiased complaints, efficacy and side effects of the therapy were studied. In the authors opinion hormone replacement therapy can be safely performed in patients with high risk factors among anamnestic data, in addition it may be useful to prevent them.

Authors+Show Affiliations

Csongrád, Szülöotthon (vezetö föorvos: Hörömpöli Csaba dr.No affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

hun

PubMed ID

8927357

Citation

Ferenc, S, and H Csaba. "[Usefulness of Transdermal Hormone Substitution in High Risk Postmenopausal Patients]." Orvosi Hetilap, vol. 137, no. 37, 1996, pp. 2025-8.
Ferenc S, Csaba H. [Usefulness of transdermal hormone substitution in high risk postmenopausal patients]. Orv Hetil. 1996;137(37):2025-8.
Ferenc, S., & Csaba, H. (1996). [Usefulness of transdermal hormone substitution in high risk postmenopausal patients]. Orvosi Hetilap, 137(37), pp. 2025-8.
Ferenc S, Csaba H. [Usefulness of Transdermal Hormone Substitution in High Risk Postmenopausal Patients]. Orv Hetil. 1996 Sep 15;137(37):2025-8. PubMed PMID: 8927357.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Usefulness of transdermal hormone substitution in high risk postmenopausal patients]. AU - Ferenc,S, AU - Csaba,H, PY - 1996/9/15/pubmed PY - 1996/9/15/medline PY - 1996/9/15/entrez SP - 2025 EP - 8 JF - Orvosi hetilap JO - Orv Hetil VL - 137 IS - 37 N2 - The authors studied whether hormone replacement therapy can be performed in postmenopausal patients with high risk factors among anamnestic data such as thromboembolia, diabetes mellitus, hypertension, epilepsy. 50 mg 17 beta estradiol patch (twice weekly) and 10 mg medroxyprogesteron (in the last 12 days of the cycle) were prescribed. Data of 102 patients with the above conditions were analyzed at the beginning and at the 3,6, and 12 month follow-up visits. The frequency of exacerbation of anamnestic disease, biased and unbiased complaints, efficacy and side effects of the therapy were studied. In the authors opinion hormone replacement therapy can be safely performed in patients with high risk factors among anamnestic data, in addition it may be useful to prevent them. SN - 0030-6002 UR - https://www.unboundmedicine.com/medline/citation/8927357/[Usefulness_of_transdermal_hormone_substitution_in_high_risk_postmenopausal_patients]_ DB - PRIME DP - Unbound Medicine ER -